Tag Archives: drug testing

Answers to Common Questions About K2/Spice

As a follow up to our recent posting about K2/Spice, below is a Q&A on the drug and issues related to testing.

Q: What is K2/Spice?
A: This is a synthetic chemical that is slightly different from THC, the active ingredient in marijuana.

Q: Is K2/ Spice illegal?
A: The Federal Government, through the DEA, made K2/Spice a Schedule 1 Drug, the most restrictive category, identifying the substances as unsafe, highly abused substances with no medical usage. That action placed K2/Spice on par with marijuana, cocaine and heroin. It is illegal to sell, possess or use these drugs.

Q: Is K2/Spice legal under the medical marijuana laws?
A: Spice is a synthetic chemical that is sprayed on a dried plant. There is no marijuana plant in K2/Spice. The synthetic marijuana chemical is different from THC. K2/Spice is not legal under any present medical marijuana law.

Q: How does K2/Spice affect someone?
A: The effects are similar to being intoxicated on marijuana. Because this is a new designer drug, risks from short or long term use are not yet known. Previous designer drugs like Ecstasy have proven to have dangerous medical consequences that were unknown in the early years of use.

Q; Will someone who smokes K2/Spice test positive on a drug screen for marijuana?
A: No. The active chemical in K2/Spice is slightly different from THC. It is different enough that it won’t test positive on a marijuana drug screen. That is why K2/Spice was invented – to avoid detection but still get the same effects as smoking marijuana.

Q: Is there a drug screen for K2/Spice?
A: Yes. CRL has created a test that will detect K2/Spice. CRL is the largest lab in the country and is federally licensed. The K2/Spice test is of the same high and accurate standards as present drug screens for marijuana. U.S. HealthWorks recommends MRO review of any positive drug screen. Each positive urine test will be confirmed by a second GC/MS test, as is the current standard practice on all drug screens.

Q: Is the collection procedure any different for K2/Spice?
A: No. Normal drug screen collection procedures are followed. No additional urine is needed. The test for K2/Spice can be administered by itself (separately) or added to any non-DOT drug screen panel.

Q: Can K2/Spice be done on a DOT test?
A: No. DOT Part 40 specifies the exact drugs to be tested in federal DOT testing. K2/Spice is not currently permitted on a DOT test.

Q: Why is there an additional charge to test for K2/Spice?
A: It is an additional and separate test from marijuana and, therefore, an additional cost is applied.

Dr. B

K2 — Not Just A Mountain Anymore

Synthetic cannabis first appeared about 8 years ago in Europe. It goes by the names Spice and K2. It is a designer drug, which means the basic marijuana molecule was altered to change its behavior. Often the goal is to increase the strength of a drug as in Ecstasy – made on the amphetamine blueprint. In the case of marijuana, the characteristic altered was the recognition that it was marijuana. A minor structural change can make a molecule unrecognizable. This was a marijuana that can’t be tested for.

It is not so much surprising that an enquiring mind could come up with a variation on the basic THC molecule, but that it was considered worth doing. Marijuana has not become an endangered species in recent years with various medical marijuana laws in 14 States.

While pot “scientists” were busy creating in their labs, the pharmaceutical laboratories were working on spoiling their plans. Tests specifically designed to recognize the synthetic marijuana molecule were developed. That isn’t too arduous a process as the initial screening test is an antibody test. An antibody to identify the new synthetic marijuana molecule is easily made. The confirming test, GCMS, only needs some synthetic marijuana to analyze, and it can happily identify synthetic marijuana down to the nanogram amount.

Of course getting around pesky government laws was the goal of this designer drug. The government simply wrote new laws outlawing this drug.

If you are concerned about the use of K2 or Spice, these can be included in your drug testing panel. Call your U.S. HealthWorks representative to enquire.

Take care.

Dr. B

Urine Drug Screening 101

Pre–employment drug testingphoto © 2011 Francis Storr | more info (via: Wylio)I see a lot of drug screens. As the National Medical Review Officer for 36,000 companies, I spend a lot of time answering questions about them. The most frequent category of question involves the numbers seen on positive urine drug screens results. I will review what these numbers mean and what they can and cannot tell you. I will try to clear up the cloudy urine, so to speak.

We’ll start with cut off levels. There is a simple concentration level that determines the “line drawn in the sand.” Any value equal or above the limit is positive, and those below the limit are negative, kind of like Black Jack.

Now to complicate matters, every positive drug screen goes through two different testing procedures. The first is called an immunoassay – this test is highly sensitive and not very specific. They can detect several variations of a drug (drugs break down into several parts in the body). In the case of marijuana, the cut off of the immunoassay is 50 ng/ml. Either the test is positive (above 50 ng/ml) and goes on to further testing, or it’s below 50 ng and is reported as negative. There is never an immunoassay numeric result.

Any positive initial test (immunoassay) will undergo a second testing of a different type-GCMS confirmation. This stands for Gas Chromatography Mass Spectrogram (don’t worry – there won’t be a test later). This is an extremely specific test that identifies one single drug variant in the urine. Because it identifies a single molecule type, the cut off level is low, 15 ng/ml in the case of marijuana. The GCMS result is the only number reported. The lab reports the test as negative if it is below 15 ng/ml. If it is above 15 ng, a quantitative number is given, like 38 or 300.

That is a lot to write down, but we are just talking a cut off level. We see cut off levels everywhere in life – 90% in school gets you an “A,” 89% a “B.” Driving 75 mph on the highway gets you there, while 80 mph gets you a ticket.

So, let’s say we have a drug screen that is positive for cocaine at 300 ng/ml (the cut off cocaine is 100 ng/ml on GCMS). Every day a company wants to know if the donor was under the influence at the time of the drug screen. The simple answer is: “I have no idea.”

That information isn’t available with a urine drug screen. The reasons are several. The most important is the concentration of drug in the urine is not the same as the concentration of drugs in the brain. Drugs in the urine don’t affect you; drugs in the brain do. The other reason a drug screen won’t reveal impairment is there are too many variables (unknowns). Among these are the donor’s dose, timing, body weight, food and drink intake, kidney and liver function. All affect the level of the drug in the system. So for a given value in urine, the donor could have arrived at that by taking hundreds of different combinations of drug amount and timing before the drug screen. So we can say the cocaine was definitely present in the urine, and it was a positive drug screen. The positive result cannot tell you if the donor is a long-term cocaine user or used it once in his life right before the drug screen. And it can’t tell you whether he was impaired (high) at the time of the drug screen.

So a urine drug screen only places the person into a user or a non-user group. We unfortunately don’t have chronic users groups and tried-it-only-once user groups to pick from.

– Dr. B

Phoenix Business Journal: Legalized Marijuana and Workplace Drug Policies

Arizona will vote next week on Proposition 203, which would legalize medical marijuana. Dr. Donald Bucklin, who oversees all drug testing for U.S. HealthWorks, shared his insights in last week’s Phoenix Business Journal on how this could affect businesses’ drug testing policies.

My View: Legalized marijuana – Will drug testing go up in smoke?

By Dr. Donald Bucklin
October 18, 2010

Juggling the need for a drug-free workplace with the rights of employees may get a lot more complicated in Arizona after the November election.

They say those who don’t understand history are doomed to repeat it.

The state of Arizona has a rich and interesting relationship with medical marijuana. The current Proposition 203 is the most recent of four similar propositions that have been on the ballot in the past 14 years.

To read the rest of the article, click here.


Bookmark and Share

Sacramento Business Journal: Office Policy Could Go Up in Smoke

By Dr. Donald Bucklin

Juggling the need for a drug-free workplace with the rights of employees might get a lot more complex in California after Nov. 2.

That’s when Proposition 19, the initiative to legalize marijuana for recreational use — not just medical reasons — will be voted on by Californians. Polls show it could very well pass.

Should the measure become law, every employer will be asking, “How does this impact my drug testing policies and my hiring process?”

As it’s currently written, Proposition 19 says that employers would retain all existing rights to address consumption of marijuana that impairs employees’ work performance.

But legalized marijuana could create significant conflicts, particularly if an employer is unprepared and doesn’t have a clear drug use policy. That’s because many employers have a zero-tolerance stance when it comes to employee drug use, conducting drug testing before and during employment.

Read the rest of the column here (subscription required).


Bookmark and Share

Businesses, Employees, Marijuana and the State of California

California now finds itself with hundreds of Medical Marijuana Dispensing Clinics and is set to vote on legalizing it completely in November.

Yet its citizens still lose jobs over marijuana positive drug screens.

So is a Medical Marijuana Card a “Get out of Jail Free Card”; or is it worth about as much as me giving you permission not to pay your taxes?

The only straight forward part of this is the law.  It starts with the Federal Government, and the DEA.   Marijuana is still listed as a Class 1 drug with LSD, Heroin and several others.  That means a doctor can’t prescribe marijuana under federal law.  Despite all arguments, unless that changes the whole California initiative may be a bit of a moot point.

Marijuana is compared to alcohol all the time.  But this is fundamentally a false comparison.  Alcohol does a lot of bad things, but is a legal drug.

The big difference between alcohol and marijuana is verifiability.  A breath alcohol or blood alcohol test can easily determine if you are impaired by alcohol.  It is inexpensive and very reliable technology.  There is no way to reliably determine if someone is impaired by marijuana.  And there lies the rub.

Everybody agrees marijuana distorts the sensorium, otherwise what’s the point.  Right this minute most large employers, private and federal, state and local, fear most that an employee can’t be proven to be impaired or unimpaired.  This uncertainty clouds this issue like uncertainty affects the stock market (negatively, with a vengeance).

So the future of marijuana is not dependent on its many physiologic effects.  Rather it is dependent on the development of technology to monitor its use.

- Dr Don Bucklin, National MRO, AKA “Dr B”


Bookmark and Share